Since ASPH has been shown to modulate the Notch and SRC pathways, we investigated whether modification of cell proliferation, migration, and invasion induced in the tested mouse tumor cell lines by knockout of ASPH and/or inhibition of the ASPH hydroxylase activity with the MO-I-1151 inhibitor can be associated with alterations in these pathways. The gene discussed is SRC; the disease is neoplasm.